Exact Sciences
EXAS
#1154
Rank
$19.17 B
Marketcap
$101.06
Share price
-0.07%
Change (1 day)
61.41%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2025 (TTM): -$0.98 Billion USD

According to Exact Sciences's latest financial reports the company's current earnings are $3.08 Billion USD. In 2024 the company made an earning of -$1.02 Billion USD a decrease over its 2023 earnings that were of -$0.19 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -$0.98 Billion-4.47%
2024 -$1.02 Billion435.05%
2023 -$0.19 Billion-69.18%
2022 -$0.62 Billion-25.77%
2021 -$0.83 Billion1.68%
2020 -$0.82 Billion271.17%
2019 -$0.22 Billion58.99%
2018 -$0.14 Billion20.89%
2017 -$0.12 Billion-30.95%
2016 -$0.17 Billion5.09%
2015 -$0.16 Billion57.24%
2014 -$0.11 Billion116.53%
2013 -$46.3 Million
2011 -$28.83 Million143.73%
2010 -$11.83 Million27.85%
2009 -$9.25 Million0.27%
2008 -$9.23 Million-20.95%
2007 -$11.67 Million-13.53%
2006 -$13.5 Million-10.07%
2005 -$15.01 Million-21.81%
2004 -$19.2 Million-33.44%
2003 -$28.84 Million-6.51%
2002 -$30.85 Million17.95%
2001 -$26.16 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Myriad Genetics
MYGN
-$0.42 Billion-56.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
$65.88 M-106.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Veracyte
VCYT
$24.74 M-102.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-$34.97 Million-96.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$9.10 B-1,038.16%๐Ÿ‡ซ๐Ÿ‡ท France